ArticleBMC veterinary research2026
Prevalence and associated bacteria of mastitis in goats in northeastern Ethiopia.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antimicrobial resistance patterns of bacteria isolated from milk samples of mastitic goats in Waghimra Zone, Amhara, Ethiopia.Veterinary and animal science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mastitis is a multifactorial disease that affects mammalian health, productivity, and public health. However, it remains considerably understudied in goats compared to cattle in Ethiopia. A cross-sectional study was conducted in selected districts of Northeastern of Amhara region between September 2024 and May 2025. The study aimed to determine the prevalence of mastitis in goats, identify the causative bacteria, and assess the associated risk factors. The detection of mastitis in goats was performed using a physical examination and the California mastitis test. Bacterial isolation and identification were performed according to established standard protocols. Statistical analysis was conducted using Stata 17 software. Among the 397 lactating goats examined, the overall mastitis prevalence at the goat level was 24.74%, comprising 2.52% clinical mastitis (CM) and 22.22% subclinical mastitis (SCM). At the udder halves level, the prevalence was 16.60%, with 1.39% CM and 15.21% SCM. Multivariable logistic regression analysis showed significant associations between goat mastitis and several factors: lactation stage (OR = 1.92; 95% CI: 1.89–6.30), district (OR = 3.47; 95% CI: 1.01–3.65), parity (OR = 2.73; 95% CI: 1.11–6.67), and previous history of mastitis (OR = 13.6; 95% CI: 4.64–40.15), all with p-values less than 0.05. Staphylococcus, E. coli, Enterococcus, and Klebsiella were identified in CM and SCM suspected cases at prevalence of 39.83%, 10.17%, 4.5%, and 2.4%, respectively. This study identified mastitis as significant production challenge-affecting goats in the study area. The findings revealed a considerable disease burden and a wide variety of bacteria, which indicates the importance of routine monitoring and the implementation of effective prevention and control measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.